Michael Lehmann, executive vice president, global sales & marketing, Patheon shares his views on the challenges ahead for the pharma sector and how they could mean greater opportunities ahead for pharmaceutical manufacturers
James Cooper, Lime Associates, supply chain specialist, looks at how strengthening supplier relationships can help pharmaceutical manufacturers to protect their businesses in 2016
Jennifer Mitcham, Catalent Biologics, offers insight into the new generation of antibody drug conjugates and the increasing importance biologics play in the fight against disease
So the pharma landscape continues to evolve. It’s interesting to witness the changes taking place, many of them using technology to improve the way medicine and drugs are administered, monitored and prescribed
EPM looks at company relationships in the pharma sector to see which companies are teaming up for new developments and which companies are ‘taking a break’
Donald Trump has said that “$300 billion could be saved” by making Medicare, the US federal health insurance programme, negotiate drug prices with pharma companies
